VivoSim Labs VIVS Peer Comparison

NASDAQ VIVS
$0.28 -0.01 (-2.38%)
At close: Sep 9, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Contract Research

VivoSim Labs, INC. (VIVS) is the 299th largest of 300 Contract Research companies by market capitalisation, at 1.47 Mn, behind MindWalk Holdings Corp. at 61.66 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 IQV Iqvia Holdings Inc. primary H-11 Pharma Services HG-03 44.06 Bn 33.68 2.59 42.11 Bn
2 MEDP Medpace Holdings, Inc. primary H-11 Pharma Services HG-03 16.50 Bn 33.89 5.93 16.00 Bn
3 CRL Charles River Laboratories International, Inc. primary H-11 Pharma Services HG-03 13.77 Bn -58.31 3.44 13.62 Bn
4 ICLR Icon Plc primary H-11 Pharma Services HG-03 12.62 Bn 16.62 1.53 11.69 Bn
5 FTRE Fortrea Holdings Inc. primary H-11 Pharma Services HG-03 1.68 Bn -19.69 0.63 1.51 Bn
6 EVO Evotec SE primary H-11 Pharma Services HG-03 0.66 Bn — — 0.24 Bn
7 DNA Ginkgo Bioworks Holdings, Inc. primary H-11 Pharma Services HG-03 0.44 Bn -1.48 3.96 0.36 Bn
8 CSBR Champions Oncology, Inc. primary H-11 Pharma Services HG-03 0.07 Bn -61.45 1.22 0.07 Bn
9 HYFT MindWalk Holdings Corp. primary H-11 Pharma Services HG-03 0.06 Bn -5.93 5.47 0.05 Bn
10 VIVS VivoSim Labs, INC. primary H-11 Pharma Services HG-03 0.00 Bn -0.13 13.10 0.00 Bn
11 NOTVQ Inotiv, Inc. primary H-11 Pharma Services HG-03 0.00 Bn 0.00 0.00 -0.01 Bn
12 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 31.49 6.77 642.33 Bn
13 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 71.80 7.04 446.51 Bn
14 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 117.16 5.57 363.78 Bn
15 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 27.00 6.20 222.38 Bn
16 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 226.93 Bn 32.34 4.90 222.99 Bn
17 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
18 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
19 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 19.66 5.48 77.10 Bn
20 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 36.92 12.23 58.75 Bn
21 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn -18.38 26.07 52.94 Bn
22 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 11.58 1.01 46.98 Bn
23 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 60.81 2.45 38.68 Bn
24 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 45.89 7.41 32.28 Bn
25 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.08 3.25 31.34 Bn
26 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
27 LH Labcorp Holdings Inc. secondary H-17 Healthcare Providers HG-04 26.44 Bn 26.61 1.84 26.32 Bn
28 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn -14.72 8.48 12.58 Bn
29 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 15.75 4.38 20.94 Bn
30 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
31 GH Guardant Health, Inc. secondary H-17 Healthcare Providers HG-04 21.57 Bn -47.30 18.23 20.51 Bn
32 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.70 Bn 22.24 2.20 18.30 Bn
33 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 18.91 11.83 15.82 Bn
34 LDOS Leidos Holdings, Inc. secondary I-02 Aerospace and Defense IG-01 16.70 Bn 12.02 0.95 16.01 Bn
35 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 16.58 3.48 14.40 Bn
36 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.28 4.69 15.42 Bn
37 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.43 12.28 14.93 Bn
38 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 17.20 6.03 13.85 Bn
39 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn -21.18 20.50 13.91 Bn
40 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
41 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.35 3.78 12.00 Bn
42 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 31.25 7.55 12.34 Bn
43 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn -45.49 18.20 10.58 Bn
44 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 74.93 14.45 11.63 Bn
45 DVA Davita Inc. secondary H-14 Healthcare Providers HG-04 11.76 Bn 10.23 0.84 12.64 Bn
46 TEM Tempus AI, Inc. secondary H-17 Healthcare Providers HG-04 11.32 Bn -46.79 7.91 10.51 Bn
47 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
48 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn -69.64 13.92 10.49 Bn
49 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.51 Bn 19.74 3.34 9.91 Bn
50 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
51 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -54.84 — 10.11 Bn
52 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 789.75 2.73 9.85 Bn
53 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
54 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn -45.28 11.01 7.57 Bn
55 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 87.02 33.42 9.42 Bn
56 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn -8.36 — 8.86 Bn
57 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 17.97 10.72 7.89 Bn
58 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.55 51.33 8.15 Bn
59 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -14.99 — 8.10 Bn
60 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -42.14 — 7.84 Bn
61 TWST Twist Bioscience Corp secondary H-10 Medical Devices and Diagnostics HG-02 7.82 Bn -56.92 18.10 7.65 Bn
62 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
63 CAI Caris Life Sciences, Inc. secondary H-17 Healthcare Providers HG-04 7.08 Bn 67.46 7.16 6.29 Bn
64 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn -33.52 29.47 6.74 Bn
65 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
66 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn -17.90 — 6.73 Bn
67 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn -29.38 1,058.74 6.59 Bn
68 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn -7.43 10.57 6.10 Bn
69 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -16.08 — 5.96 Bn
70 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.18 1,163.52 5.66 Bn
71 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
72 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -16.41 — 5.78 Bn
73 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 15.04 5.72 3.55 Bn
74 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 29.05 19.58 4.33 Bn
75 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
76 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -23.96 — 4.68 Bn
77 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
78 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn -13.51 402.01 4.16 Bn
79 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn -7.58 — 4.07 Bn
80 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.78 — 4.02 Bn
81 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -18.93 12.25 3.68 Bn
82 ADPT Adaptive Biotechnologies Corp secondary H-17 Healthcare Providers HG-04 3.86 Bn -96.41 12.54 3.53 Bn
83 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -16.67 16.41 3.01 Bn
84 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -31.20 — 3.80 Bn
85 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -32.98 70.47 2.78 Bn
86 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
87 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
88 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
89 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -21.21 52.94 3.50 Bn
90 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -10.05 19,714.47 3.11 Bn
91 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -15.22 — 3.04 Bn
92 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
93 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 109.49 6.47 2.76 Bn
94 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.23 — 2.96 Bn
95 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
96 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
97 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn -22.89 553.22 2.73 Bn
98 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
99 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 4.61 0.06 -3.12 Bn
100 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -6.02 36.49 2.60 Bn
101 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.59 Bn -174.08 10.31 2.48 Bn
102 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -6.44 — 2.59 Bn
103 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
104 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -29.70 3.21 2.16 Bn
105 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
106 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 13.72 2.56 1.65 Bn
107 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.64 44.92 1.77 Bn
108 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
109 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -17.30 1.20 1.58 Bn
110 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
111 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.96 13.89 2.36 Bn
112 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -7.91 44.88 2.34 Bn
113 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -10.51 — 1.93 Bn
114 NEO Neogenomics Inc secondary H-17 Healthcare Providers HG-04 2.22 Bn -43.43 2.90 2.08 Bn
115 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -9.16 — 2.22 Bn
116 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -15.84 109.75 2.19 Bn
117 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 13.20 4.23 2.03 Bn
118 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.66 Bn
119 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -35.67 11.42 2.05 Bn
120 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 6.66 6.86 1.69 Bn
121 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -14.21 56.15 1.81 Bn
122 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
123 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -12.36 18.84 1.60 Bn
124 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.78 20.06 1.97 Bn
125 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.72 35.35 1.39 Bn
126 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.59 6.35 1.93 Bn
127 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -9.47 67.43 1.57 Bn
128 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -101.76 4.32 0.98 Bn
129 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -6.99 — 1.32 Bn
130 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.09 7.27 1.29 Bn
131 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn -4.55 — 1.80 Bn
132 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -14.23 1,370.98 1.78 Bn
133 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -27.67 — 1.39 Bn
134 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -207.39 1,008.79 1.73 Bn
135 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
136 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.73 — 1.71 Bn
137 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.79 4.07 0.97 Bn
138 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -118.55 16.97 1.68 Bn
139 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
140 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -68.24 8.28 1.36 Bn
141 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
142 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -8.49 — 1.53 Bn
143 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -11.47 969.66 1.31 Bn
144 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
145 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
146 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -14.58 72.74 1.45 Bn
147 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -6.70 — 1.42 Bn
148 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -5.85 165.97 0.88 Bn
149 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
150 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -1.48 — 1.36 Bn
151 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.83 — 1.33 Bn
152 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.32 Bn -27.62 5.09 0.90 Bn
153 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.85 26.37 0.82 Bn
154 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.18 — 0.74 Bn
155 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -7.93 — 1.26 Bn
156 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -4.90 — 1.26 Bn
157 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.78 3.20 1.15 Bn
158 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -18.17 — 1.25 Bn
159 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.42 51.51 1.24 Bn
160 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
161 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.55 — 1.18 Bn
162 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -9.12 41.06 0.55 Bn
163 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -9.77 — 1.10 Bn
164 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn -118.02 — 1.06 Bn
165 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.93 Bn
166 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -15.63 4.14 0.71 Bn
167 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -72.45 — 0.95 Bn
168 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -16.83 2.09 0.66 Bn
169 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -4.90 14.37 0.57 Bn
170 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 2.80 3.28 0.81 Bn
171 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 20.87 8.50 0.50 Bn
172 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -16.32 881.20 0.88 Bn
173 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -11.07 104.97 0.86 Bn
174 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.78 — 0.85 Bn
175 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -8.36 — 0.84 Bn
176 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -10.71 44.17 0.48 Bn
177 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -6.79 — 0.79 Bn
178 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -124.74 2.37 0.63 Bn
179 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.55 — 0.71 Bn
180 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.12 8.48 0.61 Bn
181 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.59 5.40 0.51 Bn
182 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 554.70 9.71 0.41 Bn
183 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -3.61 — 0.49 Bn
184 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 3.17 1.81 0.62 Bn
185 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -17.73 1,120.86 0.62 Bn
186 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.59 — 0.67 Bn
187 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 5.25 1.75 0.40 Bn
188 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -362,547.56 — 0.64 Bn
189 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -12.60 16.37 0.58 Bn
190 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -10.36 — 0.63 Bn
191 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 65.43 1.94 0.05 Bn
192 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -10.13 3.65 0.47 Bn
193 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -6.80 — 0.59 Bn
194 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.04 — 0.58 Bn
195 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -3.91 557.79 0.41 Bn
196 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -4.84 — 0.56 Bn
197 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.54 Bn -6.55 2.25 0.28 Bn
198 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -16.03 326.79 0.40 Bn
199 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -10.27 78.36 0.28 Bn
200 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.66 9.32 0.22 Bn
201 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -15.37 — 0.50 Bn
202 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.49 Bn -6.01 330.55 0.49 Bn
203 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 15.82 2.57 0.42 Bn
204 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 16.24 2.11 0.39 Bn
205 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -8.13 — 0.47 Bn
206 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
207 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -3.41 — 0.47 Bn
208 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -4.85 13.19 0.21 Bn
209 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -5.63 100.68 0.36 Bn
210 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.72 15.31 0.26 Bn
211 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.48 — 0.45 Bn
212 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.68 44.52 0.24 Bn
213 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -5.85 — 0.44 Bn
214 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.58 42.40 0.44 Bn
215 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -7.97 19.43 0.16 Bn
216 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.45 — 0.43 Bn
217 CLPT ClearPoint Neuro, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.43 Bn -14.46 10.07 0.40 Bn
218 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -6.49 6.28 0.22 Bn
219 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.27 — 0.24 Bn
220 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -1.28 139.55 0.21 Bn
221 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.78 — 0.38 Bn
222 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.38 Bn -8.69 0.45 0.27 Bn
223 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
224 WDH Waterdrop Inc. secondary F-16 Insurance FG-04 0.38 Bn 4.82 0.51 0.21 Bn
225 DMAC DiaMedica Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -11.03 — 0.36 Bn
226 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.16 — 0.36 Bn
227 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 3.71 2.65 0.34 Bn
228 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.13 — 0.34 Bn
229 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -6.68 — 0.33 Bn
230 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.93 3.70 0.17 Bn
231 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.05 104.23 0.33 Bn
232 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -7.83 5.52 0.16 Bn
233 IMRX Immuneering Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -5.31 — 0.31 Bn
234 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -4.33 — 0.31 Bn
235 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.31 Bn -4.97 6.82 0.26 Bn
236 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -10.84 — 0.31 Bn
237 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.58 4.90 0.30 Bn
238 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
239 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.32 13.14 0.29 Bn
240 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.29 7.86 0.22 Bn
241 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.03 0.01 -10.78 Bn
242 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -17.36 1.67 0.17 Bn
243 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -3.35 — 0.28 Bn
244 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.82 59.24 0.28 Bn
245 BDSX Biodesix Inc secondary H-17 Healthcare Providers HG-04 0.28 Bn -9.39 2.68 0.25 Bn
246 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -7.64 — 0.27 Bn
247 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.12 19.81 0.10 Bn
248 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.35 23.24 0.27 Bn
249 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -18.88 — 0.15 Bn
250 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.82 1.20 0.11 Bn
251 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -13.77 — 0.25 Bn
252 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.77 17.81 0.21 Bn
253 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -1.49 — 0.25 Bn
254 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 6.88 3.31 0.16 Bn
255 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.15 4.34 0.08 Bn
256 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -10.43 — 0.23 Bn
257 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.42 — 0.23 Bn
258 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.20 — 0.23 Bn
259 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -5.11 54.32 0.23 Bn
260 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -1.16 — 0.23 Bn
261 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 6.84 -0.03 Bn
262 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.58 0.22 Bn
263 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.22 Bn -2.20 0.48 0.17 Bn
264 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.66 4.31 0.11 Bn
265 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -4.44 10.20 0.08 Bn
266 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.46 — 0.19 Bn
267 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.99 — 0.22 Bn
268 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.58 6.23 0.10 Bn
269 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.05 2.66 0.17 Bn
270 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.27 — 0.21 Bn
271 ADAG Adagene Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -13.14 32.66 0.21 Bn
272 AGPU Axe Compute Inc. secondary T-44 Cloud Computing TG-07 0.21 Bn -8.43 — 0.19 Bn
273 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.55 15.49 0.17 Bn
274 ORMP Oramed Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 1.21 — 0.21 Bn
275 NBP NovaBridge Biosciences secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.47 — 0.20 Bn
276 IPHA Innate Pharma SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.16 60.09 0.19 Bn
277 QNCX Quince Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.55 — 0.34 Bn
278 NGEN Nervgen Pharma Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -116.03 — 0.19 Bn
279 XGN Exagen Inc. secondary H-17 Healthcare Providers HG-04 0.18 Bn -9.68 2.58 0.16 Bn
280 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.61 75.57 0.06 Bn
281 MOLN Molecular Partners Ag secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
282 XLO Xilio Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
283 ADCT ADC Therapeutics SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.42 2.28 -0.05 Bn
284 MDWD MediWound Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -4.87 14.38 0.14 Bn
285 RANI Rani Therapeutics Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.96 33.39 0.17 Bn
286 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 2,035.87 -0.02 Bn
287 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.91 — 0.16 Bn
288 NRXP NRX Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.25 43.96 0.12 Bn
289 KRMD KORU Medical Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.15 Bn -63.82 3.33 0.14 Bn
290 MIST Milestone Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
291 ENTX Entera Bio Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.49 — 0.14 Bn
292 OKUR OnKure Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.87 — -0.03 Bn
293 UNCY Unicycive Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.06 — 0.14 Bn
294 CUE Cue Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.72 6.38 0.13 Bn
295 MSLE Satellos Bioscience Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.56 — 0.14 Bn
296 CRBP Corbus Pharmaceuticals Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
297 IBIO iBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.13 1,363.19 0.14 Bn
298 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.47 — 0.14 Bn
299 MXCT Maxcyte, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 0.14 Bn -3.84 4.38 0.14 Bn
300 IMDX Insight Molecular Diagnostics Inc. secondary H-08 Medical Devices and Diagnostics HG-02 0.13 Bn -2.80 80.68 0.12 Bn